DJIA 17,050.75 138.46 0.82%
NASDAQ 4,810.79 19.64 0.41%
S&P 500 2,013.43 17.60 0.88%
market minute promo

GlaxoSmithKline (NYSE: GSK)

40.16 0.44 (1.11%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $40.16 1.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $39.53
Previous Close $39.72
Daily Range $39.49 - $40.16
52-Week Range $37.24 - $49.08
Market Cap $87.2B
P/E Ratio 13.65
Dividend (Yield) $2.31 (6.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,772,720
Average Daily Volume 3,518,937
Current FY EPS $2.39




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary Rss Feed

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?

Bristol-Myers to Pay $14M to Settle China Bribe Charges

9 Sector-Leading Dividend Dogs Average 20% Yields As Of September 30

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

3 Drugs Stocks Moving The Industry Upward

Mirna Therapeutics: A Healthy IPO To Start The Week

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing

GlaxoSmithKline (GSK) Stock: Is the Worst Over?

See More GSK News...

GSK's Top Competitors

GSK $40.16 (1.11%)
Current stock: GSK
JNJ $95.08 (0.11%)
Current stock: JNJ
NVS $92.61 (1.10%)
Current stock: NVS
RHHBY $33.29 (2.26%)
Current stock: RHHBY